Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis

Hepatology

Volumn 42, Issue 2, 2005, Pages 273-281

  Lau, Daryl T Y ^a,b   Luxon, Bruce A ^a   Xiao, Shu Yuan ^a,b   Beard, Michael R ^a,c   Lemon, Stanley M ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLYCOLIPID; MESSENGER RNA; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR;

APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CLINICAL ARTICLE; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMALE; FIBROGENESIS; GENE EXPRESSION PROFILING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIPID METABOLISM; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; STELLATE CELL;

ACTINS; ADULT; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 23044515033     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20767     Document Type: Article

References (33)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
2. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986;315:1575-1578.
3. Mahoney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, et al. Genotypic analysis of hepatitis C virus in American patients. HEPATOLOGY 1994;20:1405-1411.
4. Lau JY, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian K, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996;124:868-876.
5. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al. Recombinant interferon for chronic hepatitis C. A randomized double-blind placebo-controlled trial. N Engl J Med 1989; 321:1506-1510.
6. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362:2095-2100.
7. Shiffman ML. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation. Liver Transpl 2003;9(Suppl):S14-S20.
8. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
9. Friedman SL. Hepatic stellate cells. Progress Liver Dis 1996;14:101-130.
10. Guido M, Rugge M, Leandro G, Fiel IM, Thung SN. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts. HEPATOLOGY 1997;2:310-314.
11. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995;22:28-36.
12. Khan MA, Poulos JE, Brunt EM, Li L, Solomon H, Britton RS, et al. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy. Hepatogastroenterology 2001;48:212-215.
13. Guido M, Rugge M, Chemello L, Leandro G, Fattovich G, Giustina G, et al. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. J Hepatol 1996;24:301-307.
14. Schmitt-Graff A, Kruger S, Bochard F, Gabbiani G, Denk H, Darby I, et al. Modulation of the alpha smooth muscle actin and desmin expression in perisinusoidal cells in normal and diseased human livers. Am J Pathol 1991;138:1233-1242
15. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-5121.
16. Yauk CL, Berndt ML, Williams A, Douglas GR. Comprehensive comparison of six microarray technologies. Nucl Acids Res 2004;32:1-7.
17. Rogojina AT, Orr WE, Song BK, Geisert EE. Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. Mol Vis 2003;9:482-496.
18. Li J, Pankratz M, Johnson JA. Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays. Toxicol Sci 2002;69: 383-390.
19. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
20. Nieto N, Friedman SL, Cederbaum AI. Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen 1 protein synthesis by hepatic stellate cells. J Biol Chem 2002;277:9853-9864.
21. Houglum K, Venkataramani A, Lyche K, Chojkier M. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroemerology 1997;113:1069-1073.
22. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 2002;99:15669-15674.
23. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al. Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroemerology 2002;122: 366.
24. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis c virus-associated hepatocarcinogenesis, Cancer Res 2001;61:4365.
25. Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A 2001;98:9599.
26. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003;112:1383-1394.
27. Chang KM. Immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2003;7:89-105.
28. Mizukoshi E, Rehermann B. Immune responses and immunity in hepatitis C virus infection. J Gastroenterol 2001;36:799-808.
29. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
30. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in Interferon gamma-deficient mice infected with Leishmania major. J Exp Med 1994;179:1367-1371.
31. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 1997;94:10663-10668.
32. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002;52: 19-24.
33. Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, Carles J, et al. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol 1999;189:46-52.